对于表型驱动的变体和基因优先级算法的标准基准:PhEval - 表型推断评估框架
Yasemin Bridges1, Vinicius de Souza2, Katherina G Cortes3
1William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, EC1M 6BQ, UK.
开发有效的罕见疾病诊断工具是一项挑战. PhEval提供了一个标准化的框架来对基因变异和基因优先级算法 (VGPA) 进行基准测试,改善罕见疾病诊断和患者护理.
科学领域:
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
- 基因组学就是基因组学.
背景情况:
- 罕见疾病诊断依赖于复杂的计算工具,如变异和基因优先级算法 (VGPA).
- 由于缺乏标准化的框架,可复制的数据和一致的方法,评估和比较VGPA很困难.
- 这阻碍了开发和采用有效的罕见病诊断管道.
研究的目的:
- 推出PhEval,这是一款旨在规范化基于表型的VGPA评估的新基准测试工具.
- 解决当前VGPA评估方法的可复制性和可比性的局限性.
主要方法:
- 开发PhEval,一个基准测试工具,结合了标准化测试机构和发电公用事业.
- 利用现实世界患者病例报告数据创建标准化数据集进行评估.
- 在基准测试期间控制VGPA的配置,以确保一致性.
主要成果:
- PhEval为评估VGPA提供了一个标准化和经验框架.
- 该工具包括标准化测试机构和用于开放基准测试的生成工具.
- PhEval使VGPA的透明,便携式,可比,可重复的评估成为可能.
结论:
- PhEval及其相关机构克服了罕见疾病VGPA基准测试数据可用性和工具配置方面的挑战.
- 这种标准化的方法对于提高罕见疾病诊断工具的准确性和可靠性至关重要.
- 改进的VGPA评估直接有助于更好的患者诊断和治疗罕见遗传疾病.
更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
00:06In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
Published on: August 20, 2019
相关概念视频
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Incomplete Dominance
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Gene Evolution - Fast or Slow?
In contrast, regions which code...
